Exploring the biological behavior and underlying mechanism of KITLG in triple-negative breast cancer
Authors:
Open Access
- 1 January 2024
- journal article
- research article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 15 (3) , 764-775
Abstract
The tyrosine-kinase receptor that is specified by the KIT locus is demarcated by KITLG. This multifaceted factor is instrumental during in-utero germ and neural cell maturation and hematopoiesis, ostensibly reflecting its role in facilitating cell migration. Concurrently, KITLG is prone to a mutation in germ cell tumors, entailing a presumed connection to tumorigenesis. Despite this, the intricacies of its function in breast cancer and the relevant mechanisms remain elusive. Multiple independent databases depict a consistently low expression of KITLG within tissues affected by triple-negative breast cancers (TNBC), a trend strongly coupled with reduced survival rates. Interestingly, non-triple-negative breast cancers exhibit a markedly high expression of KITLG compared to the norm. An initial analysis of the GEO database speculates that KITLG may serve as an oncogene suppressor in TNBC, hinting at varied roles for KITLG isoforms within this disease context. In conclusion, our preliminary analysis offers valuable insights into the role and expression pattern of KITLG in TNBC. We provide evidence supporting its consideration as a promising new prognostic marker, thereby potentially enriching therapeutic strategies for TNBC. Indeed, given the limited advances in molecularly targeted therapy for TNBC, a significant need exists for a more precise therapeutic approach and a comprehensive understanding of its inherent mechanisms of action.Keywords
This publication has 27 references indexed in Scilit:
- A novel slug-containing negative-feedback loop regulates SCF/c-Kit-mediated hematopoietic stem cell self-renewalLeukemia, 2016
- Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivoBMC Cancer, 2015
- Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein KinasesMicrobiology and Molecular Biology Reviews, 2011
- Triple-Negative Breast CancerNew England Journal of Medicine, 2010
- KIT activation in uterine cervix adenosquamous carcinomas by KIT/SCF autocrine/paracrine stimulation loopsGynecologic Oncology, 2008
- Neuronal and glioma-derived stem cell factor induces angiogenesis within the brainCancer Cell, 2006
- Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrine/paracrine mechanismBritish Journal of Cancer, 2006
- Circulating Growth Factor Levels Are Associated with Tumorigenesis in Neurofibromatosis Type 1Clinical Cancer Research, 2004
- Roles of Stem Cell Factor/c-Kit and Effects of Glivec®/STI571 in Human Uveal Melanoma Cell TumorigenesisJournal of Biological Chemistry, 2004
- Stem Cell Factor/c-kit Up-regulates Cyclin D3 and Promotes Cell Cycle Progression via the Phosphoinositide 3-Kinase/p70 S6 Kinase Pathway in SpermatogoniaJournal of Biological Chemistry, 2000